News

In recognition of Mental Health Awareness Month, the AHA has refreshed its website highlighting the important roles hospitals and health systems play in behavioral health care, as well as resources from the AHA and other organizations addressing the importance of behavioral health care for patients and communities.

A blog by the AHA and Press Ganey shares insights from leaders of seven health care systems on balancing the demands of delivering personalized, high-quality care and the urgent need to support a stretched and often overwhelmed workforce.

The AHA May 5 will award Jim Leonard, M.D., president and CEO of Carle Health in Urbana, Ill., the 2025 Justin Ford Kimball Innovators Award during the AHA Annual Membership Meeting in Washington, D.C.

The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge their ability to provide care to their patients and communities.

The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options.

The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for calculating Medicare Disproportionate Share Hospital payments.

The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483).

The AHA May 5 will award Mary Beth Kingston, Ph.D., its 2025 Award of Honor during the AHA Annual Membership Meeting in Washington, D.C.

During the 2025 AHA Annual Membership Meeting in Washington, D.C., the AHA will present Melinda Estes, M.D., former president and CEO of Saint Luke's Health System, and Rod Hochman, M.D., former president and CEO of Providence Health and Services, with its highest honor — the Distinguished Service Award — for their longtime service to the AHA and the field.

The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical requirements for devices installed in national security systems.

A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer patients instead of traditional methods such as chemotherapy, radiation or surgery.

I welcomed John Riggi, AHA’s National Advisor for Cybersecurity and Risk, to our Leadership Dialogue to have a conversation about planning for and navigating cyber and physical threats.

There have been 884 confirmed cases of measles nationwide so far this year, with cases reported by 29 states, according to the latest data from the Centers for Disease Control and Prevention.

The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride Injection 500mg/100mL Infusion bags due to the products potentially containing inert polypropylene fibers.

We need to talk about protecting access to care by rejecting cuts to Medicaid, additional so-called site-neutral payment policies and harmful changes to the 340B program.

The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel rupture and a vasospasm.

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., April 24 released a report detailing findings from an investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program.

A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of an accident by 25%.

The deadline for health delivery organizations to apply for the AHA’s 2026 Foster G. McGaw Prize is 1 p.m. ET May 6. The award honors organizations that demonstrate alignment between community health needs and co-designed programs.

A JAMA Internal Medicine study published April 7 examined the effects of changing the default prescription lengths for statins, which are cholesterol-lowering medications, from 2022 to 2024. The study noted that higher rates of possession of such medications are often associated with a lower risk of death.